Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing 100084, People's Republic of China.
Biofabrication. 2020 Aug 12;12(4):045020. doi: 10.1088/1758-5090/aba4ff.
We first proposed the concept of in situ in vivo bioprinting in order to address the existing deficiencies in conventional bioprinting. Herein we verified this concept taking the case of the treatment for gastric wall injury and presented this work as a preliminary step towards a new method in the field of bioprinting. In this study, a micro bioprinting platform which can be installed to an endoscope was developed to enter the human body and process bioprinting. Printed circuit micro-electro-mechanical-system techniques were used in the design and fabrication of the platform. Control system with high accuracy was developed and performance tests were carried out to verify the feasibility of the platform. The 2-layer tissue scaffolds were printed in a stomach model. Gelatin-alginate hydrogels with human gastric epithelial cells and human gastric smooth muscle cells were used as bioinks to mimic the anatomical structure of a stomach. A 10 d cell culture showed that printed cells remained a high viability and a steady proliferation, which indicated good biological function of cells in printed tissue scaffolds. This work presents an innovative advance not only in the field of bioprinting but also in the clinical sciences.
我们首先提出了原位活体生物打印的概念,以解决传统生物打印中存在的缺陷。在此,我们以胃壁损伤的治疗为例验证了这一概念,并将这项工作作为生物打印领域的一种新方法的初步步骤。在这项研究中,开发了一种可安装在内窥镜上的微生物打印平台,以进入人体并进行生物打印。该平台的设计和制造采用了印刷电路板微机电系统技术。开发了高精度的控制系统,并进行了性能测试,以验证平台的可行性。在胃模型中打印了 2 层组织支架。使用人胃上皮细胞和人胃平滑肌细胞的明胶-海藻酸盐水凝胶作为生物墨水,以模拟胃的解剖结构。10 天的细胞培养表明,打印的细胞仍然具有高活力和稳定的增殖,这表明打印组织支架中的细胞具有良好的生物学功能。这项工作不仅在生物打印领域,而且在临床科学领域都取得了创新性的进展。